Simultaneous liver-kidney transplantation: future perspective.

End-stage renal disease Hypothermic machine perfusion Liver transplantation Simultaneous liver-kidney transplantation

Journal

World journal of urology
ISSN: 1433-8726
Titre abrégé: World J Urol
Pays: Germany
ID NLM: 8307716

Informations de publication

Date de publication:
20 Aug 2024
Historique:
received: 22 04 2023
accepted: 11 07 2024
medline: 20 8 2024
pubmed: 20 8 2024
entrez: 20 8 2024
Statut: epublish

Résumé

The aims of this narrative review were (i) to describe the current indications of SLKT, (ii) to report evolution of SLKT activity, (iii) to report the outcomes of SLKT, (iv) to explain the immune-protective effect of liver transplant on kidney transplant, (v) to explain the interest of delay kidney transplantation, using hypothermic machine perfusion (HMP), (vi) to report kidney after liver transplantation (KALT) indications and (vii) to describe the value of the increase in the use of extended criteria donors (ECD) and particular controlled donation after circulatory death (cDCD) transplant, thanks to the development of new organ preservation strategies. Electronic databases were screened using the keywords "Simultaneous", "Combined", "kidney transplantation" and "liver transplantation". The methodological and clinical heterogeneity of the included studies meant that meta-analysis was inappropriate.  A total of 1,917 publications were identified in the literature search. Two reviewers screened all study abstracts independently and 1,107 of these were excluded. Thus, a total of 79 full text articles were assessed for eligibility. Of these, 21 were excluded. In total, 58 studies were included in this systematic review.  Simultaneous liver-kidney transplantation has made a significant contribution for patients with dual-organ disease. The optimization of indication and selection of SLKT patients will reduce futile transplantation. Moreover, increasing the use of transplants from extended criteria donors, in particular cDCD, should be encouraged, thanks to the development of new modalities of organ preservation.

Sections du résumé

BACKGROUND BACKGROUND
The aims of this narrative review were (i) to describe the current indications of SLKT, (ii) to report evolution of SLKT activity, (iii) to report the outcomes of SLKT, (iv) to explain the immune-protective effect of liver transplant on kidney transplant, (v) to explain the interest of delay kidney transplantation, using hypothermic machine perfusion (HMP), (vi) to report kidney after liver transplantation (KALT) indications and (vii) to describe the value of the increase in the use of extended criteria donors (ECD) and particular controlled donation after circulatory death (cDCD) transplant, thanks to the development of new organ preservation strategies.
METHOD METHODS
Electronic databases were screened using the keywords "Simultaneous", "Combined", "kidney transplantation" and "liver transplantation". The methodological and clinical heterogeneity of the included studies meant that meta-analysis was inappropriate.
RESULTS RESULTS
 A total of 1,917 publications were identified in the literature search. Two reviewers screened all study abstracts independently and 1,107 of these were excluded. Thus, a total of 79 full text articles were assessed for eligibility. Of these, 21 were excluded. In total, 58 studies were included in this systematic review.
CONCLUSIONS CONCLUSIONS
 Simultaneous liver-kidney transplantation has made a significant contribution for patients with dual-organ disease. The optimization of indication and selection of SLKT patients will reduce futile transplantation. Moreover, increasing the use of transplants from extended criteria donors, in particular cDCD, should be encouraged, thanks to the development of new modalities of organ preservation.

Identifiants

pubmed: 39162870
doi: 10.1007/s00345-024-05174-z
pii: 10.1007/s00345-024-05174-z
doi:

Types de publication

Journal Article Systematic Review Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

489

Informations de copyright

© 2024. The Author(s).

Références

Saxena V, Lai JC (2015) Kidney failure and liver allocation: current practices and potential improvements. Adv Chronic Kidney Dis 22(5):391–398. https://doi.org/10.1053/j.ackd.2015.05.002
doi: 10.1053/j.ackd.2015.05.002 pubmed: 26311601 pmcid: 4556134
Minnee RC, Darwish Murad S, Polak WG, Metselaar HJ (2019) Combined liver-kidney transplantation: two for the price of one? Transpl Int 32(9):913–915. https://doi.org/10.1111/tri.13438
doi: 10.1111/tri.13438 pubmed: 30963624
Stepanova M, Wai H, Saab S, Mishra A, Venkatesan C, Younossi ZM (2015) The outcomes of adult liver transplants in the United States from 1987 to 2013. Liver Int 35(8):2036–2041. https://doi.org/10.1111/liv.12779
doi: 10.1111/liv.12779 pubmed: 25559873
Bahirwani R, Reddy KR (2009) Outcomes after liver transplantation: chronic kidney disease. Liver Transpl 15(Suppl 2):S70–74. https://doi.org/10.1002/lt.21900
doi: 10.1002/lt.21900 pubmed: 19876956
Nair S, Verma S, Thuluvath PJ (2002) Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 35(5):1179–1185. https://doi.org/10.1053/jhep.2002.33160
doi: 10.1053/jhep.2002.33160 pubmed: 11981768
Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW, Arndorfer J, Christensen L, Merion RM (2003) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349(10):931–940. https://doi.org/10.1056/NEJMoa021744
doi: 10.1056/NEJMoa021744 pubmed: 12954741
Margreiter R, Kramar R, Huber C, Steiner E, Niederwieser D, Judmaier G, Vogel W (1984) Combined liver and kidney transplantation. Lancet 1(8385):1077–1078. https://doi.org/10.1016/s0140-6736(84)91486-7
doi: 10.1016/s0140-6736(84)91486-7 pubmed: 6144007
Sharma P, Shu X, Schaubel DE, Sung RS, Magee JC (2016) Propensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction. Liver Transpl 22(1):71–79. https://doi.org/10.1002/lt.24189
doi: 10.1002/lt.24189 pubmed: 26069168 pmcid: 4674390
Singal AK, Salameh H, Kuo YF, Wiesner RH (2014) Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology. Transplantation 98(2):216–221. https://doi.org/10.1097/TP.0000000000000048
doi: 10.1097/TP.0000000000000048 pubmed: 24621538
Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N (2006) Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us? Am J Transpl 6(11):2651–2659. https://doi.org/10.1111/j.1600-6143.2006.01526.x
doi: 10.1111/j.1600-6143.2006.01526.x
Formica RN, Aeder M, Boyle G, Kucheryavaya A, Stewart D, Hirose R, Mulligan D (2016) Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of Scarce resources. Am J Transpl 16(3):758–766. https://doi.org/10.1111/ajt.13631
doi: 10.1111/ajt.13631
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097
doi: 10.1371/journal.pmed.1000097 pubmed: 19621072 pmcid: 2707599
Chava SP, Singh B, Zaman MB, Rela M, Heaton ND (2009) Current indications for combined liver and kidney transplantation in adults. Transpl Rev (Orlando) 23(2):111–119. https://doi.org/10.1016/j.trre.2009.01.005
doi: 10.1016/j.trre.2009.01.005
Asch WS, Bia MJ (2017) New Organ Allocation System for Combined liver-kidney transplants and the availability of kidneys for transplant to patients with stage 4–5 CKD. Clin J Am Soc Nephrol 12(5):848–852. https://doi.org/10.2215/CJN.08480816
doi: 10.2215/CJN.08480816 pubmed: 28028050
Singal AK, Ong S, Satapathy SK, Kamath PS, Wiesner RH (2019) Simultaneous liver kidney transplantation. Transpl Int 32(4):343–352. https://doi.org/10.1111/tri.13388
doi: 10.1111/tri.13388 pubmed: 30548094
Buccheri S, Da BL (2022) Hepatorenal Syndrome: definitions, diagnosis, and management. Clin Liver Dis 26(2):181–201. https://doi.org/10.1016/j.cld.2022.01.002
doi: 10.1016/j.cld.2022.01.002 pubmed: 35487604
Koppel MH, Coburn JW, Mims MM, Goldstein H, Boyle JD, Rubini ME (1969) Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med 280(25):1367–1371. https://doi.org/10.1056/NEJM196906192802501
doi: 10.1056/NEJM196906192802501 pubmed: 4890476
Iwatsuki S, Popovtzer MM, Corman JL, Ishikawa M, Putnam CW, Katz FH, Starzl TE (1973) Recovery from hepatorenal syndrome after orthotopic liver transplantation. N Engl J Med 289(22):1155–1159. https://doi.org/10.1056/NEJM197311292892201
doi: 10.1056/NEJM197311292892201 pubmed: 4585359 pmcid: 2772065
O’Leary JG, Levitsky J, Wong F, Nadim MK, Charlton M, Kim WR (2016) Protecting the kidney in liver transplant candidates: practice-based recommendations from the American Society of Transplantation Liver and Intestine Community of Practice. Am J Transpl 16(9):2516–2531. https://doi.org/10.1111/ajt.13790
doi: 10.1111/ajt.13790
Nair G, Nair V (2022) Simultaneous liver-kidney transplantation. Clin Liver Dis 26(2):313–322. https://doi.org/10.1016/j.cld.2022.01.011
doi: 10.1016/j.cld.2022.01.011 pubmed: 35487613
Nadim MK, Sung RS, Davis CL, Andreoni KA, Biggins SW, Danovitch GM, Feng S, Friedewald JJ, Hong JC, Kellum JA, Kim WR, Lake JR, Melton LB, Pomfret EA, Saab S, Genyk YS (2012) Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transpl 12(11):2901–2908. https://doi.org/10.1111/j.1600-6143.2012.04190.x
doi: 10.1111/j.1600-6143.2012.04190.x
OPTN/SRTR (2019) Annual Data Report: Liver. https://srtr.transplant.hrsa.gov/annual_reports/2019/Liver.aspx#LI_tx_slk_b64
Rapport d’activité (2019) de transplantation de l’Agence de Biomédecine https://rams.agence-biomedecine.fr/sites/default/files/pdf/2020-09/RAMS%202019%20ORGANES%20Rein.pdf
Guide du score Foie https://www.agence-biomedecine.fr/IMG/pdf/guide_score_foie_v3.pdf
Tinti F, Mitterhofer AP, Umbro I, Nightingale P, Inston N, Ghallab M, Ferguson J, Mirza DF, Ball S, Lipkin G, Muiesan P, Perera M (2019) Combined liver-kidney transplantation versus liver transplant alone based on KDIGO stratification of estimated glomerular filtration rate: data from the United Kingdom Transplant registry - a retrospective cohort study. Transpl Int 32(9):918–932. https://doi.org/10.1111/tri.13413
doi: 10.1111/tri.13413 pubmed: 30793378
Aguilera V, Ferrer I, Berenguer M, Rivera J, Rubin A, Moya A, Pareja E, Sanchez J, Prieto M, Mir J (2013) Comparison of results of combined liver-kidney transplantation vs. isolated liver transplantation. Ann Hepatol 12(2):274–281
doi: 10.1016/S1665-2681(19)31366-3 pubmed: 23396739
Hibi T, Sageshima J, Molina E, Ciancio G, Nishida S, Chen L, Arosemena L, Mattiazzi A, Guerra G, Kupin W, Tekin A, Selvaggi G, Levi D, Ruiz P, Livingstone AS, Roth D, Martin P, Tzakis A, Burke GW (2012) Predisposing factors of diminished survival in simultaneous liver/kidney transplantation. Am J Transpl 12(11):2966–2973. https://doi.org/10.1111/j.1600-6143.2012.04121.x
doi: 10.1111/j.1600-6143.2012.04121.x
Hmoud B, Kuo YF, Wiesner RH, Singal AK (2015) Outcomes of liver transplantation alone after listing for simultaneous kidney: comparison to simultaneous liver kidney transplantation. Transplantation 99(4):823–828. https://doi.org/10.1097/TP.0000000000000438
doi: 10.1097/TP.0000000000000438 pubmed: 25250648
Fong TL, Khemichian S, Shah T, Hutchinson IV, Cho YW (2012) Combined liver-kidney transplantation is preferable to liver transplant alone for cirrhotic patients with renal failure. Transplantation 94(4):411–416. https://doi.org/10.1097/TP.0b013e3182590d6b
doi: 10.1097/TP.0b013e3182590d6b pubmed: 22805440
Nadim MK, Genyk YS, Tokin C, Fieber J, Ananthapanyasut W, Ye W, Selby R (2012) Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome. Liver Transpl 18(5):539–548. https://doi.org/10.1002/lt.23384
doi: 10.1002/lt.23384 pubmed: 22250075
Fong TL, Bunnapradist S, Jordan SC, Selby RR, Cho YW (2003) Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 76(2):348–353. https://doi.org/10.1097/01.TP.0000071204.03720.BB
doi: 10.1097/01.TP.0000071204.03720.BB pubmed: 12883191
Simpson N, Cho YW, Cicciarelli JC, Selby RR, Fong TL (2006) Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database. Transplantation 82(10):1298–1303. https://doi.org/10.1097/01.tp.0000241104.58576.e6
doi: 10.1097/01.tp.0000241104.58576.e6 pubmed: 17130778
Fung J, Makowka L, Tzakis A, Klintmalm G, Duquesnoy R, Gordon R, Todo S, Griffin M, Starzl T (1988) Combined liver-kidney transplantation: analysis of patients with preformed lymphocytotoxic antibodies. Transpl Proc 20(1 Suppl 1):88–91
Rasmussen A, Davies HF, Jamieson NV, Evans DB, Calne RY (1995) Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59(6):919–921
doi: 10.1097/00007890-199503270-00025 pubmed: 7701595
Zhang X, Wisel SA, Haas M, Kim I, Jordan S (2022) Both donor specific and non-donor specific HLA antibodies reduced in recipients post simultaneous liver/kidney transplant. Transpl Immunol 75:101744. https://doi.org/10.1016/j.trim.2022.101744
doi: 10.1016/j.trim.2022.101744 pubmed: 36372143
Cholbi E, Espi J, Ventura A, Ramos D, Ramos M, Luis M, Moreno E, Moreno M, Beneyto I, Hernandez J (2022) Combined liver-kidney transplantation in high immunologic risk recipients: kidney graft evolution. Transpl Proc 54(9):2475–2478. https://doi.org/10.1016/j.transproceed.2022.10.007
doi: 10.1016/j.transproceed.2022.10.007
Sumimoto R, Kamada N (1990) Specific suppression of allograft rejection by soluble class I antigen and complexes with monoclonal antibody. Transplantation 50(4):678–682. https://doi.org/10.1097/00007890-199010000-00029
doi: 10.1097/00007890-199010000-00029 pubmed: 2219291
Habib S, Khan K, Hsu CH, Meister E, Rana A, Boyer T (2017) Differential Simultaneous liver and kidney transplant benefit based on severity of liver damage at the Time of Transplantation. Gastroenterol Res 10(2):106–115. https://doi.org/10.14740/gr803w
doi: 10.14740/gr803w
Ekser B, Mangus RS, Fridell W, Kubal CA, Nagai S, Kinsella SB, Bayt DR, Bell TM, Powelson JA, Goggins WC, Tector AJ (2017) A Novel Approach in Combined liver and kidney transplantation with long-term outcomes. Ann Surg 265(5):1000–1008. https://doi.org/10.1097/SLA.0000000000001752
doi: 10.1097/SLA.0000000000001752 pubmed: 28398965
Lunsford KE, Agopian VG, Yi SG, Nguyen DTM, Graviss EA, Harlander-Locke MP, Saharia A, Kaldas FM, Mobley CM, Zarrinpar A, Hobeika MJ, Veale JL, Podder H, Farmer DG, Knight RJ, Danovitch GM, Gritsch HA, Li XC, Ghobrial RM, Busuttil RW, Gaber AO (2020) Delayed implantation of pumped kidneys decreases renal allograft futility in combined liver-kidney transplantation. Transplantation 104(8):1591–1603. https://doi.org/10.1097/TP.0000000000003040
doi: 10.1097/TP.0000000000003040 pubmed: 32732836
Mangus RS, Lutz AJ, Fridell JA, Kubal CA, Bush WJ, Tector AJ (2015) Minimal improvement in glomerular filtration rate in the First Year after Liver Transplantation. Transplantation 99(9):1855–1861. https://doi.org/10.1097/TP.0000000000000668
doi: 10.1097/TP.0000000000000668 pubmed: 26308416
Ekser B, Mangus RS, Kubal CA, Powelson JA, Fridell JA, Goggins WC (2018) Excellent outcomes in combined liver-kidney transplantation: impact of kidney donor profile index and delayed kidney transplantation. Liver Transpl 24(2):222–232. https://doi.org/10.1002/lt.24946
doi: 10.1002/lt.24946 pubmed: 28926173
Chang A, Schaubel DE, Chen M, Abt PL, Bittermann T (2022) Trends and Outcomes of Hypothermic Machine Perfusion Preservation of Kidney Allografts in simultaneous liver and kidney transplantation in the United States. Transpl Int 35:10345. https://doi.org/10.3389/ti.2022.10345
doi: 10.3389/ti.2022.10345 pubmed: 35356400 pmcid: 8958417
Cullaro G, Verna EC, Emond JC, Orandi BJ, Mohan S, Lai JC (2021) Early kidney allograft failure after simultaneous liver-kidney transplantation: evidence for utilization of the Safety Net? Transplantation 105(4):816–823. https://doi.org/10.1097/TP.0000000000003310
doi: 10.1097/TP.0000000000003310 pubmed: 32413016 pmcid: 7971118
Nunez-Nateras R, Reddy KS, Aqel BA, Heilman R, Morgan P, Mathur AK, Hewitt W, Heimbach J, Rosen C, Moss AA, Taner T, Jadlowiec CC (2020) Simultaneous liver-kidney transplantation from donation after cardiac death donors: an updated perspective. Am J Transpl 20(12):3582–3589. https://doi.org/10.1111/ajt.16191
doi: 10.1111/ajt.16191
Croome KP, Mao S, Yang L, Pungpapong S, Wadei HM, Taner CB (2020) Improved National results with simultaneous liver-kidney transplantation using donation after circulatory death donors. Liver Transpl 26(3):397–407. https://doi.org/10.1002/lt.25653
doi: 10.1002/lt.25653 pubmed: 31599050
LaMattina JC, Mezrich JD, Fernandez LA, D’Alessandro AM, Bellingham JM, Musat AI, Foley DP (2011) Simultaneous liver and kidney transplantation using donation after cardiac death donors: a brief report. Liver Transpl 17(5):591–595. https://doi.org/10.1002/lt.22264
doi: 10.1002/lt.22264 pubmed: 21506247 pmcid: 3088423
Johnson LB, Plotkin JS, Howell CD, Njoku MJ, Kuo PC, Bartlett ST (1997) Successful emergency transplantation of a liver allograft from a donor maintained on extracorporeal membrane oxygenation. Transplantation 63(6):910–911
doi: 10.1097/00007890-199703270-00021 pubmed: 9089236
Sutherland AI, Oniscu GC (2016) Challenges and advances in optimizing liver allografts from donation after circulatory death donors. J Nat Sci Biol Med 7(1):10–15. https://doi.org/10.4103/0976-9668.175017
doi: 10.4103/0976-9668.175017 pubmed: 27003962 pmcid: 4780154
Hessheimer AJ, de la Rosa G, Gastaca M, Ruiz P, Otero A, Gomez M, Alconchel F, Ramirez P, Bosca A, Lopez-Andujar R, Atutxa L, Royo-Villanova M, Sanchez B, Santoyo J, Marin LM, Gomez-Bravo MA, Mosteiro F, Villegas Herrera MT, Villar Del Moral, Gonzalez-Abos J, Vidal C, Lopez-Dominguez B, Llado J, Roldan L, Justo J, Jimenez I, Lopez-Monclus C, Sanchez-Turrion J, Rodriguez-Laiz V, Velasco Sanchez G, Lopez-Baena E, Caralt JA, Charco M, Tome R, Varo S, Marti-Cruchaga E, Rotellar P, Varona F, Barrera MA, Rodriguez-Sanjuan M, Briceno JC, Lopez J, Blanco D, Nuno G, Pacheco J, Coll D, Dominguez-Gil E, Fondevila B (2022) C Abdominal normothermic regional perfusion in controlled donation after circulatory determination of death liver transplantation: Outcomes and risk factors for graft loss. Am J Transplant 22 (4):1169–1181. https://doi.org/10.1111/ajt.16899
Watson CJE, Hunt F, Messer S, Currie I, Large S, Sutherland A, Crick K, Wigmore SJ, Fear C, Cornateanu S, Randle LV, Terrace JD, Upponi S, Taylor R, Allen E, Butler AJ, Oniscu GC (2019) In situ normothermic perfusion of livers in controlled circulatory death donation may prevent ischemic cholangiopathy and improve graft survival. Am J Transpl 19(6):1745–1758. https://doi.org/10.1111/ajt.15241
doi: 10.1111/ajt.15241
Savier E, Lim C, Rayar M, Orlando F, Boudjema K, Mohkam K, Lesurtel M, Mabrut JY, Pittau G, Begdadi N, Cherqui D, Adam R, Dondero F, Sepulveda A, Soubrane O, Bucur P, Barbier L, Salame E, Jasseron C, Antoine C, Riou B, Scatton O (2020) Favorable outcomes of liver transplantation from controlled circulatory death donors using Normothermic Regional Perfusion compared to Brain Death Donors. Transplantation 104(9):1943–1951. https://doi.org/10.1097/TP.0000000000003372
doi: 10.1097/TP.0000000000003372 pubmed: 32639402
Sade RM (2005) Transplantation at 100 years: Alexis Carrel, pioneer surgeon. Ann Thorac Surg 80(6):2415–2418. https://doi.org/10.1016/j.athoracsur.2005.08.074
doi: 10.1016/j.athoracsur.2005.08.074 pubmed: 16305931
Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ (2009) Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 360(1):7–19. https://doi.org/10.1056/NEJMoa0802289
doi: 10.1056/NEJMoa0802289 pubmed: 19118301
Monbaliu D, Pirenne J, Talbot D (2012) Liver transplantation using donation after Cardiac Death donors. J Hepatol 56(2):474–485. https://doi.org/10.1016/j.jhep.2011.07.004
doi: 10.1016/j.jhep.2011.07.004 pubmed: 21782762
Nasralla D, Coussios CC, Mergental H, Akhtar MZ, Butler AJ, Ceresa CDL, Chiocchia V, Dutton SJ, Garcia-Valdecasas JC, Heaton N, Imber C, Jassem W, Jochmans I, Karani J, Knight SR, Kocabayoglu P, Malago M, Mirza D, Morris PJ, Pallan A, Paul A, Pavel M, Perera M, Pirenne J, Ravikumar R, Russell L, Upponi S, Watson CJE, Weissenbacher A, Ploeg RJ, Friend PJ, Consortium for Organ Preservation in E (2018) A randomized trial of normothermic preservation in liver transplantation. Nature 557(7703):50–56. https://doi.org/10.1038/s41586-018-0047-9
doi: 10.1038/s41586-018-0047-9 pubmed: 29670285
Schlegel A, Mueller M, Muller X, Eden J, Panconesi R, von Felten S, Steigmiller K, Sousa Da Silva RX, de Rougemont O, Mabrut JY, Lesurtel M, Cerisuelo MC, Heaton ND, Allard MA, Adam R, Monbaliu D, Jochmans I, Haring MPD, Porte RJ, Parente A, Muiesan P, Kron P, Attia M, Kollmann D, Berlakovich G, Rogiers X, Petterson K, Kranich AL, Amberg S, Mullhaupt B, Clavien PA, Dutkowski P (2023) A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. J Hepatol. https://doi.org/10.1016/j.jhep.2022.12.030
doi: 10.1016/j.jhep.2022.12.030 pubmed: 38110006
Muller X, Mohkam K, Mueller M, Schlegel A, Dondero F, Sepulveda A, Savier E, Scatton O, Bucur P, Salame E, Jeddou H, Sulpice L, Pittau G, Allard MA, Mabrut JY, Dutkowski P, Clavien PA, Lesurtel M (2020) Hypothermic oxygenated perfusion Versus Normothermic Regional Perfusion in Liver Transplantation from controlled donation after circulatory death: First International Comparative Study. Ann Surg 272(5):751–758. https://doi.org/10.1097/SLA.0000000000004268
doi: 10.1097/SLA.0000000000004268 pubmed: 32833758
Gaurav R, Butler AJ, Kosmoliaptsis V, Mumford L, Fear C, Swift L, Fedotovs A, Upponi S, Khwaja S, Richards J, Allison M, Watson CJE (2022) Liver transplantation outcomes from controlled circulatory death donors: SCS vs in situ NRP vs ex situ NMP. Ann Surg 275(6):1156–1164. https://doi.org/10.1097/SLA.0000000000005428
doi: 10.1097/SLA.0000000000005428 pubmed: 35258511
Hessheimer AJ, Coll E, Torres F, Ruiz P, Gastaca M, Rivas JI, Gomez M, Sanchez B, Santoyo J, Ramirez P, Parrilla P, Marin LM, Gomez-Bravo MA, Garcia-Valdecasas JC, Lopez-Monclus J, Bosca A, Lopez-Andujar R, Fundora-Suarez J, Villar J, Garcia-Sesma A, Jimenez C, Rodriguez-Laiz G, Llado L, Rodriguez JC, Barrera M, Charco R, Lopez-Baena JA, Briceno J, Pardo F, Blanco G, Pacheco D, Dominguez-Gil B, Sanchez Turrion V, Fondevila C (2019) Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation. J Hepatol 70(4):658–665. https://doi.org/10.1016/j.jhep.2018.12.013
doi: 10.1016/j.jhep.2018.12.013 pubmed: 30582980
Schlegel A, Muller X, Kalisvaart M, Muellhaupt B, Perera M, Isaac JR, Clavien PA, Muiesan P, Dutkowski P (2019) Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation. J Hepatol 70(1):50–57. https://doi.org/10.1016/j.jhep.2018.10.005
doi: 10.1016/j.jhep.2018.10.005 pubmed: 30342115
Czigany Z, Pratschke J, Fronek J, Guba M, Schoning W, Raptis DA, Andrassy J, Kramer M, Strnad P, Tolba RH, Liu W, Keller T, Miller H, Pavicevic S, Uluk D, Kocik M, Lurje I, Trautwein C, Mehrabi A, Popescu I, Vondran FWR, Ju C, Tacke F, Neumann UP, Lurje G (2021) Hypothermic oxygenated machine perfusion reduces early allograft Injury and improves post-transplant outcomes in Extended Criteria Donation Liver Transplantation from Donation after Brain Death: results from a Multicenter Randomized Controlled Trial (HOPE ECD-DBD). Ann Surg 274(5):705–712. https://doi.org/10.1097/SLA.0000000000005110
doi: 10.1097/SLA.0000000000005110 pubmed: 34334635
Mohkam K, Nasralla D, Mergental H, Muller X, Butler A, Jassem W, Imber C, Monbaliu D, Perera M, Laing RW, Garcia-Valdecasas JC, Paul A, Dondero F, Cauchy F, Savier E, Scatton O, Robin F, Sulpice L, Bucur P, Salame E, Pittau G, Allard MA, Pradat P, Rossignol G, Mabrut JY, Ploeg RJ, Friend PJ, Mirza DF, Lesurtel M Consortium for Organ Preservation in E (2022) in situ normothermic regional perfusion versus ex situ normothermic machine perfusion in liver transplantation from donation after circulatory death. Liver Transpl 28 (11):1716–1725. https://doi.org/10.1002/lt.26522

Auteurs

Thomas Prudhomme (T)

Department of Urology, Kidney Transplantation and Andrology, TSA 50032 Rangueil Hospital, Toulouse Cedex 9, 31059, France. prudhomme.t@chu-toulouse.fr.
Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, Nantes, 44000, France. prudhomme.t@chu-toulouse.fr.

Benoit Mesnard (B)

Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, Nantes, 44000, France.
Department of Urology, University Hospital of Nantes, Nantes, France.

Julien Branchereau (J)

Center for Research in Transplantation and Translational Immunology, Nantes Université, INSERM, UMR 1064, Nantes, 44000, France.
Department of Urology, University Hospital of Nantes, Nantes, France.

Mathieu Roumiguié (M)

Department of Urology, Kidney Transplantation and Andrology, TSA 50032 Rangueil Hospital, Toulouse Cedex 9, 31059, France.

Charlotte Maulat (C)

Department of Digestive Surgery, University Hospital of Rangueil, Toulouse, France.

Fabrice Muscari (F)

Department of Digestive Surgery, University Hospital of Rangueil, Toulouse, France.

Nassim Kamar (N)

Department of Nephrology and Organ Transplantation, University Hospital of Rangueil, Toulouse, France.

Michel Soulié (M)

Department of Urology, Kidney Transplantation and Andrology, TSA 50032 Rangueil Hospital, Toulouse Cedex 9, 31059, France.

Xavier Gamé (X)

Department of Urology, Kidney Transplantation and Andrology, TSA 50032 Rangueil Hospital, Toulouse Cedex 9, 31059, France.

Federico Sallusto (F)

Department of Urology, Kidney Transplantation and Andrology, TSA 50032 Rangueil Hospital, Toulouse Cedex 9, 31059, France.

Marc Olivier Timsit (MO)

Department of Urology, Hôpital Européen Georges Pompidou, APHP-Centre, Paris, France.

Sarah Drouin (S)

Service Médico-Chirurgical de Transplantation Rénale, APHP Sorbonne-Université, Hôpital Pitié-Salpêtrière, Paris, Île-de-France, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH